2,024
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prognostic and Predictive Value of Epigenetic Biomarkers and Clinical Factors in Upper Tract Urothelial Carcinoma

, , , , , , , , , , , , , , , , , , , , , & show all
Pages 733-744 | Published online: 27 Apr 2015

References

  • Rouprêt M1 , BabjukM , CompératEet al. European guidelines on upper tract urothelial carcinomas: 2013 update . Eur. Urol.63 ( 6 ), 1059 – 1071 ( 2013 ).
  • Siegel R , MaJ , ZouZ , JemalA . Cancer statistics, 2014 . CA Cancer J. Clin.64 ( 1 ), 9 – 29 ( 2014 ).
  • Catto JW , AzzouziAR , RehmanIet al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma . J. Clin. Oncol.23 ( 13 ), 2903 – 2910 ( 2005 ).
  • Yu J , ZhuT , WangZet al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer . Clin. Cancer Res.13 ( 24 ), 7296 – 7304 ( 2007 ).
  • Maruyama R , ToyookaS , ToyookaKOet al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features . Cancer Res.61 ( 24 ), 8659 – 8663 ( 2001 ).
  • Costa VL1 , HenriqueR , DanielsenSAet al. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples . Clin. Cancer Res.16 ( 23 ), 5842 – 5851 ( 2010 ).
  • Lee MG , KimHY , ByunDSet al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma . Cancer Res.61 ( 18 ), 6688 – 6692 ( 2001 ).
  • Casadio V1 , MolinariC , CalistriDet al. DNA Methylation profiles as predictors of recurrence in non-muscle invasive bladder cancer: an MS-MLPA approach . J. Exp. Clin. Cancer Res.32 , 94 ( 2013 ).
  • Fang D , XiongG , LiXet al. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population . Urol. Oncol.33 ( 2 ), 66.e1 – 66.e11 ( 2015 ).
  • TNM Classification Of Malignant Tumours. Urological tumours, renal pelvis and ureter. Sobin LH , GospodarowiczMK , WittekindC ( Eds ). Wiley-Blackwell, NY USA , 258 – 261 ( 2009 ).
  • Mostofi FK , SobinLH , TorloniH . Histological typing of urinary bladder tumours . WHO ( 1973 ). http://whqlibdoc.who.int .
  • Herman JG , GraffJR , MyöhänenS , NelkinBD , BaylinSB . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands . Proc. Natl Acad. Sci. USA93 ( 18 ), 9821 – 9826 ( 1996 ).
  • Kang GH , ShimYH , JungHY , KimWH , RoJY , RhyuMG . CpG island methylation in premalignant stages of gastric carcinoma . Cancer Res.61 ( 7 ), 2847 – 2851 ( 2001 ).
  • Frank E Harrell Jr . Rms Package. R package version 4.2-1 . http://cran.r-project.org
  • Monteiro-Reis S , LeçaL , AlmeidaMet al. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation . Eur. J. Cancer50 ( 1 ), 226 – 233 ( 2014 ).
  • Hsu NC , HuangYF , YokoyamaKK , ChuPY , ChenFM , HouMF . Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer . PLoS ONE8 ( 2 ), e56256 ( 2013 ).
  • Chen XP , XiongGY , LiXSet al. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China . BJU Int.112 ( 7 ), 917 – 924 ( 2013 ).
  • Chou YH , HuangCH . Unusual clinical presentation of upper urothelial carcinoma in Taiwan . Cancer85 , 1342 – 1344 ( 1999 ).
  • Yang MH , ChenKK , YenCCet al. Unusually high incidence of upper tract urothelial carcinoma in Taiwan . Urology59 , 681 – 687 ( 2002 ).
  • Lughezzani G , JeldresC , IsbarnHet al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients . Eur. J. Cancer45 , 3291 – 3297 ( 2009 ).
  • Rouprêt M , TraxerO , TliguiMet al. Upper urinary tract urothelial carcinoma: recurrence rate after percutaneous endoscopic resection . Eur. Urol.51 , 709 ( 2007 ).
  • Fernández MI , ShariatSF , MargulisVet al. Evidence-based sex related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study . Urology73 , 142 – 146 ( 2009 ).
  • Munoz JJ , EllisonLM . Upper tract urothelial neoplasms: incidence and survival during the last 2 decades . J. Urol.164 , 1525 – 1532 ( 2000 ).
  • Chen CH , DickmanKG , HuangCYet al. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes . Int. J. Cancer133 ( 1 ), 14 – 20 ( 2013 ).
  • Nortier JL , MartinezMC , SchmeiserHHet al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) . N. Engl. J. Med.342 ( 23 ), 1686 – 1692 ( 2000 ).
  • Cukuranovic R , IgnjatovicI , VisnjicMet al. Characteristics of upper urothelial carcinoma in an area of Balkan endemic nephropathy in South Serbia. A fifty-year retrospective study . Tumori96 , 674 – 679 ( 2010 ).
  • Paul A , PaulS . The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers . Front. Biosci. (Landmark Ed).19 , 605 – 618 ( 2014 ).
  • Byrski T , DentR , BlecharzPet al. Results of a Phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer . Breast Cancer Res.14 ( 4 ), R110 ( 2012 ).
  • Luo HL , KangCH , ChenYTet al. Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma . Ann. Surg. Oncol.20 ( 9 ), 3121 – 3126 ( 2013 ).
  • Hafner C , KnuechelR , ZanardoLet al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract . Oncogene20 , 4910 – 4915 ( 2001 ).
  • Matsui Y , UtsunomiyaN , IchiokaKet al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract . Urology65 ( 2 ), 279 – 283 ( 2005 ).
  • Terakawa T , MiyakeH , MuramakiM , TakenakaA , HaraI , FujisawaM . Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract . Urology71 ( 1 ), 123 – 127 ( 2008 ).
  • Hisataki T , MiyaoN , MasumoriNet al. Risk factors for the development of bladder cancer after upper tract urothelial cancer . Urology55 ( 5 ), 663 – 667 ( 2000 ).
  • Eling TE , BaekSJ , ShimM , LeeCH . NSAID activated gene (NAG-1), a modulator of tumorigenesis . J. Biochem. Mol. Biol.39 ( 6 ), 649 – 655 ( 2006 ).
  • Mimeault M , BatraSK . Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer . J. Cell. Physiol.3 , 626 – 635 ( 2010 ).
  • Fang D , XiongGY , LiXSet al. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience . J. Formos. Med. Assoc.113 ( 11 ), 820 – 827 ( 2014 ).